Pfizer's new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets.
Mar 2, 2022
0
3
In the recent film "Don't Look Up," two astronomers learn that a comet is on track to collide with Earth and destroy human civilization. When they try to sound the alarm, all manner of obstacles get in their way. In the end, ...
Feb 16, 2022
0
2
Playing with dolls can prompt children to talk about others' thoughts and emotions, according to the latest findings of a multi-year study from neuroscientists at Cardiff University.
Feb 8, 2022
0
35
President Joe Biden announced a relaunch of the government's cancer "moonshot" effort in a White House ceremony Wednesday, setting a goal of cutting the US death rate from the disease by half.
Feb 2, 2022
0
9
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.
Jan 25, 2022
0
2
The Biden administration will begin making 400 million N95 masks available for free to U.S. residents starting next week, now that federal officials are emphasizing their better protection against the omicron variant of COVID-19 ...
Jan 19, 2022
0
36
(HealthDay)—Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant.
Nov 30, 2021
0
1
Since 1971, when the U.S. government made defeating cancer a goal and put major funding behind it, death rates for many cancers have plummeted, but some are increasing, according to a new American Cancer Society report.
Nov 11, 2021
0
11
Another important step in the fight against cancer has been enabled thanks in part to research from BYU scientists. Dr. Josh Andersen, who heads the university's Fritz B. Burns Cancer Research Laboratory, discovered the mechanism ...
Oct 6, 2021
0
125
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The ...
Oct 5, 2021
0
11
